Loading…
Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials
The purpose of this meta-analysis was to evaluate the effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome (PCOS). We performed a literature search of databases and identified randomized controlled trials (RCTs) published prior to December 2019. A meta...
Saved in:
Published in: | Gynecological endocrinology 2021-05, Vol.37 (5), p.446-455 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c366t-5eff43e15d3dec6b056c7284ea21a8cc3a3fd4eb633826ce65301d6d1a48ff073 |
---|---|
cites | cdi_FETCH-LOGICAL-c366t-5eff43e15d3dec6b056c7284ea21a8cc3a3fd4eb633826ce65301d6d1a48ff073 |
container_end_page | 455 |
container_issue | 5 |
container_start_page | 446 |
container_title | Gynecological endocrinology |
container_volume | 37 |
creator | Wang, Li Wen, Xinqiang Lv, Shulan Tian, Sijuan Jiang, Yifan Yang, Xiaofeng |
description | The purpose of this meta-analysis was to evaluate the effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome (PCOS).
We performed a literature search of databases and identified randomized controlled trials (RCTs) published prior to December 2019. A meta-analysis was conducted using RevMan 5.3 and Stata 12.0 software. We compared the effects of vitamin D supplementation alone to the administration of placebos on metabolic parameters of PCOS women with vitamin D deficiency.
Ten articles of RCTs were included and analyzed in this meta-analysis, which included a total of 520 PCOS women. Our meta-analysis results showed no significant effects of vitamin D supplementation on BMI (p = .43), systolic blood pressure (p = .05), diastolic blood pressure (p = .87), fasting insulin concentration (p = .86), HOMA-IR (p = .47), HDL-C (p = .76), LDL-C (p = .23) and triglyceride (p = .77). Both low dose vitamin D supplementation ( |
doi_str_mv | 10.1080/09513590.2020.1813272 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_32909865</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2441607585</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-5eff43e15d3dec6b056c7284ea21a8cc3a3fd4eb633826ce65301d6d1a48ff073</originalsourceid><addsrcrecordid>eNp9kdtuFSEUhomxsbvVR9Bw6c1UDgMz2ytNbWuTJt7oNWHDImIYGIHdnfE9fN-yD_XShGRx-D5W4EfoLSVXlIzkA1kLysWaXDHC2tZIORvYC7Si_cA7Mkj5Eq32TLeHztFFKb8Iobwf2Ct0ztmarEcpVujvjXNgasHJ4Udf9eQj_oLLdp4DTBCrrj5F3MYEVW9S8AbPOuu2gnyQdqlheOfrTzynsJil1MakR50XXJZoczv_iPXB73TUYSn-IGYdbZr8H7DYpFhzCqFNa_Y6lNfozLUCb071Ev24vfl-_bV7-HZ3f_35oTNcytoJcK7nQIXlFozcECHNwMYeNKN6NIZr7mwPG8n5yKQBKTihVlqq-9E5MvBL9P5475zT7y2UqiZfDISgI6RtUazvqSSDGEVDxRE1OZWSwak5-6m9UlGi9omo50TUPhF1SqR5704ttpsJ7D_rOYIGfDoCPrqUJ71LOVhV9RJSdu2TjC-K_7_HE--Ynr8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2441607585</pqid></control><display><type>article</type><title>Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Wang, Li ; Wen, Xinqiang ; Lv, Shulan ; Tian, Sijuan ; Jiang, Yifan ; Yang, Xiaofeng</creator><creatorcontrib>Wang, Li ; Wen, Xinqiang ; Lv, Shulan ; Tian, Sijuan ; Jiang, Yifan ; Yang, Xiaofeng</creatorcontrib><description>The purpose of this meta-analysis was to evaluate the effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome (PCOS).
We performed a literature search of databases and identified randomized controlled trials (RCTs) published prior to December 2019. A meta-analysis was conducted using RevMan 5.3 and Stata 12.0 software. We compared the effects of vitamin D supplementation alone to the administration of placebos on metabolic parameters of PCOS women with vitamin D deficiency.
Ten articles of RCTs were included and analyzed in this meta-analysis, which included a total of 520 PCOS women. Our meta-analysis results showed no significant effects of vitamin D supplementation on BMI (p = .43), systolic blood pressure (p = .05), diastolic blood pressure (p = .87), fasting insulin concentration (p = .86), HOMA-IR (p = .47), HDL-C (p = .76), LDL-C (p = .23) and triglyceride (p = .77). Both low dose vitamin D supplementation (<4000 IU/day) and high dose vitamin D supplementation (≥4000 IU/day) were found to significantly decreased the fasting glucose concentration (p = .01, p = .001, respectively). Vitamin D supplementation significantly decreased total cholesterol concentration (p = .03).
The results of this meta-analysis suggested that vitamin D supplementation decreases fasting glucose concentration and total cholesterol concentration in PCOS women with vitamin D deficiency.</description><identifier>ISSN: 0951-3590</identifier><identifier>EISSN: 1473-0766</identifier><identifier>DOI: 10.1080/09513590.2020.1813272</identifier><identifier>PMID: 32909865</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Blood Glucose - drug effects ; Dietary Supplements ; Female ; Humans ; Lipid Metabolism - drug effects ; meta-analysis ; metabolic parameters ; polycystic ovary syndrome ; Polycystic Ovary Syndrome - drug therapy ; randomized controlled trials ; Randomized Controlled Trials as Topic ; Vitamin D - pharmacology ; Vitamin D - therapeutic use ; Vitamin D supplementation ; Vitamins - pharmacology ; Vitamins - therapeutic use</subject><ispartof>Gynecological endocrinology, 2021-05, Vol.37 (5), p.446-455</ispartof><rights>2020 Informa UK Limited, trading as Taylor & Francis Group 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-5eff43e15d3dec6b056c7284ea21a8cc3a3fd4eb633826ce65301d6d1a48ff073</citedby><cites>FETCH-LOGICAL-c366t-5eff43e15d3dec6b056c7284ea21a8cc3a3fd4eb633826ce65301d6d1a48ff073</cites><orcidid>0000-0002-7631-4984</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32909865$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Wen, Xinqiang</creatorcontrib><creatorcontrib>Lv, Shulan</creatorcontrib><creatorcontrib>Tian, Sijuan</creatorcontrib><creatorcontrib>Jiang, Yifan</creatorcontrib><creatorcontrib>Yang, Xiaofeng</creatorcontrib><title>Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials</title><title>Gynecological endocrinology</title><addtitle>Gynecol Endocrinol</addtitle><description>The purpose of this meta-analysis was to evaluate the effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome (PCOS).
We performed a literature search of databases and identified randomized controlled trials (RCTs) published prior to December 2019. A meta-analysis was conducted using RevMan 5.3 and Stata 12.0 software. We compared the effects of vitamin D supplementation alone to the administration of placebos on metabolic parameters of PCOS women with vitamin D deficiency.
Ten articles of RCTs were included and analyzed in this meta-analysis, which included a total of 520 PCOS women. Our meta-analysis results showed no significant effects of vitamin D supplementation on BMI (p = .43), systolic blood pressure (p = .05), diastolic blood pressure (p = .87), fasting insulin concentration (p = .86), HOMA-IR (p = .47), HDL-C (p = .76), LDL-C (p = .23) and triglyceride (p = .77). Both low dose vitamin D supplementation (<4000 IU/day) and high dose vitamin D supplementation (≥4000 IU/day) were found to significantly decreased the fasting glucose concentration (p = .01, p = .001, respectively). Vitamin D supplementation significantly decreased total cholesterol concentration (p = .03).
The results of this meta-analysis suggested that vitamin D supplementation decreases fasting glucose concentration and total cholesterol concentration in PCOS women with vitamin D deficiency.</description><subject>Blood Glucose - drug effects</subject><subject>Dietary Supplements</subject><subject>Female</subject><subject>Humans</subject><subject>Lipid Metabolism - drug effects</subject><subject>meta-analysis</subject><subject>metabolic parameters</subject><subject>polycystic ovary syndrome</subject><subject>Polycystic Ovary Syndrome - drug therapy</subject><subject>randomized controlled trials</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Vitamin D - pharmacology</subject><subject>Vitamin D - therapeutic use</subject><subject>Vitamin D supplementation</subject><subject>Vitamins - pharmacology</subject><subject>Vitamins - therapeutic use</subject><issn>0951-3590</issn><issn>1473-0766</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kdtuFSEUhomxsbvVR9Bw6c1UDgMz2ytNbWuTJt7oNWHDImIYGIHdnfE9fN-yD_XShGRx-D5W4EfoLSVXlIzkA1kLysWaXDHC2tZIORvYC7Si_cA7Mkj5Eq32TLeHztFFKb8Iobwf2Ct0ztmarEcpVujvjXNgasHJ4Udf9eQj_oLLdp4DTBCrrj5F3MYEVW9S8AbPOuu2gnyQdqlheOfrTzynsJil1MakR50XXJZoczv_iPXB73TUYSn-IGYdbZr8H7DYpFhzCqFNa_Y6lNfozLUCb071Ev24vfl-_bV7-HZ3f_35oTNcytoJcK7nQIXlFozcECHNwMYeNKN6NIZr7mwPG8n5yKQBKTihVlqq-9E5MvBL9P5475zT7y2UqiZfDISgI6RtUazvqSSDGEVDxRE1OZWSwak5-6m9UlGi9omo50TUPhF1SqR5704ttpsJ7D_rOYIGfDoCPrqUJ71LOVhV9RJSdu2TjC-K_7_HE--Ynr8</recordid><startdate>20210504</startdate><enddate>20210504</enddate><creator>Wang, Li</creator><creator>Wen, Xinqiang</creator><creator>Lv, Shulan</creator><creator>Tian, Sijuan</creator><creator>Jiang, Yifan</creator><creator>Yang, Xiaofeng</creator><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7631-4984</orcidid></search><sort><creationdate>20210504</creationdate><title>Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials</title><author>Wang, Li ; Wen, Xinqiang ; Lv, Shulan ; Tian, Sijuan ; Jiang, Yifan ; Yang, Xiaofeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-5eff43e15d3dec6b056c7284ea21a8cc3a3fd4eb633826ce65301d6d1a48ff073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Blood Glucose - drug effects</topic><topic>Dietary Supplements</topic><topic>Female</topic><topic>Humans</topic><topic>Lipid Metabolism - drug effects</topic><topic>meta-analysis</topic><topic>metabolic parameters</topic><topic>polycystic ovary syndrome</topic><topic>Polycystic Ovary Syndrome - drug therapy</topic><topic>randomized controlled trials</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Vitamin D - pharmacology</topic><topic>Vitamin D - therapeutic use</topic><topic>Vitamin D supplementation</topic><topic>Vitamins - pharmacology</topic><topic>Vitamins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Wen, Xinqiang</creatorcontrib><creatorcontrib>Lv, Shulan</creatorcontrib><creatorcontrib>Tian, Sijuan</creatorcontrib><creatorcontrib>Jiang, Yifan</creatorcontrib><creatorcontrib>Yang, Xiaofeng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecological endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Li</au><au>Wen, Xinqiang</au><au>Lv, Shulan</au><au>Tian, Sijuan</au><au>Jiang, Yifan</au><au>Yang, Xiaofeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials</atitle><jtitle>Gynecological endocrinology</jtitle><addtitle>Gynecol Endocrinol</addtitle><date>2021-05-04</date><risdate>2021</risdate><volume>37</volume><issue>5</issue><spage>446</spage><epage>455</epage><pages>446-455</pages><issn>0951-3590</issn><eissn>1473-0766</eissn><abstract>The purpose of this meta-analysis was to evaluate the effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome (PCOS).
We performed a literature search of databases and identified randomized controlled trials (RCTs) published prior to December 2019. A meta-analysis was conducted using RevMan 5.3 and Stata 12.0 software. We compared the effects of vitamin D supplementation alone to the administration of placebos on metabolic parameters of PCOS women with vitamin D deficiency.
Ten articles of RCTs were included and analyzed in this meta-analysis, which included a total of 520 PCOS women. Our meta-analysis results showed no significant effects of vitamin D supplementation on BMI (p = .43), systolic blood pressure (p = .05), diastolic blood pressure (p = .87), fasting insulin concentration (p = .86), HOMA-IR (p = .47), HDL-C (p = .76), LDL-C (p = .23) and triglyceride (p = .77). Both low dose vitamin D supplementation (<4000 IU/day) and high dose vitamin D supplementation (≥4000 IU/day) were found to significantly decreased the fasting glucose concentration (p = .01, p = .001, respectively). Vitamin D supplementation significantly decreased total cholesterol concentration (p = .03).
The results of this meta-analysis suggested that vitamin D supplementation decreases fasting glucose concentration and total cholesterol concentration in PCOS women with vitamin D deficiency.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>32909865</pmid><doi>10.1080/09513590.2020.1813272</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-7631-4984</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0951-3590 |
ispartof | Gynecological endocrinology, 2021-05, Vol.37 (5), p.446-455 |
issn | 0951-3590 1473-0766 |
language | eng |
recordid | cdi_pubmed_primary_32909865 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | Blood Glucose - drug effects Dietary Supplements Female Humans Lipid Metabolism - drug effects meta-analysis metabolic parameters polycystic ovary syndrome Polycystic Ovary Syndrome - drug therapy randomized controlled trials Randomized Controlled Trials as Topic Vitamin D - pharmacology Vitamin D - therapeutic use Vitamin D supplementation Vitamins - pharmacology Vitamins - therapeutic use |
title | Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A55%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20vitamin%20D%20supplementation%20on%20metabolic%20parameters%20of%20women%20with%20polycystic%20ovary%20syndrome:%20a%20meta-analysis%20of%20randomized%20controlled%20trials&rft.jtitle=Gynecological%20endocrinology&rft.au=Wang,%20Li&rft.date=2021-05-04&rft.volume=37&rft.issue=5&rft.spage=446&rft.epage=455&rft.pages=446-455&rft.issn=0951-3590&rft.eissn=1473-0766&rft_id=info:doi/10.1080/09513590.2020.1813272&rft_dat=%3Cproquest_pubme%3E2441607585%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-5eff43e15d3dec6b056c7284ea21a8cc3a3fd4eb633826ce65301d6d1a48ff073%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2441607585&rft_id=info:pmid/32909865&rfr_iscdi=true |